LLSCX
Price
$29.36
Change
-$0.15 (-0.51%)
Updated
Nov 12 closing price
Net Assets
740.06M
VSCIX
Price
$122.65
Change
+$0.19 (+0.16%)
Updated
Nov 12 closing price
Net Assets
161.58B
Interact to see
Advertisement

LLSCX vs VSCIX

Header iconLLSCX vs VSCIX Comparison
Open Charts LLSCX vs VSCIXBanner chart's image
Longleaf Partners Small-Cap
Price$29.36
Change-$0.15 (-0.51%)
VolumeN/A
Net Assets740.06M
Vanguard Small Cap Index I
Price$122.65
Change+$0.19 (+0.16%)
VolumeN/A
Net Assets161.58B
LLSCX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
LLSCX vs. VSCIX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLSCX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 162B vs. LLSCX (740M). VSCIX pays higher dividends than LLSCX: VSCIX (1.35) vs LLSCX (0.11). LLSCX was incepted earlier than VSCIX: LLSCX (37 years) vs VSCIX (28 years). LLSCX (1.04) is less costly to investors than VSCIX (0.04). LLSCX is a more actively managed with annual turnover of: 27.00 vs. VSCIX (13.00). LLSCX has a lower initial minimum investment than VSCIX: LLSCX (10000) vs VSCIX (5000000). LLSCX annual gain was more profitable for investors over the last year : 3.93 vs. VSCIX (1.45). VSCIX return over 5 years is better than : 48.42 vs. LLSCX (33.85).
LLSCXVSCIXLLSCX / VSCIX
Total Expense Ratio0.950.042,375%
Annual Report Gross Expense Ratio1.040.042,600%
Fund Existence37 years28 years-
Gain YTD7.3106.768108%
Front LoadN/AN/A-
Min. Initial Investment1000050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets740M162B0%
Annual Yield % from dividends0.111.358%
Returns for 1 year3.931.45271%
Returns for 3 years37.3633.27112%
Returns for 5 years33.8548.4270%
Returns for 10 years25.57138.3418%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAMI44.540.56
+1.27%
Acadian Asset Management Inc
TAVIU10.44N/A
N/A
Tavia Acquisition Corp
SCM12.07-0.01
-0.08%
STELLUS CAPITAL INVESTMENT Corp
CYTK65.94-0.56
-0.84%
Cytokinetics
CUE0.67-0.02
-2.25%
Cue Biopharma